TY - JOUR
T1 - Hypoglycaemia incidence and recovery during home use of hybrid closed-loop insulin delivery in adults with type 1 diabetes
AU - Ruan, Yue
AU - Bally, Lia
AU - Thabit, Hood
AU - Leelarathna, Lalantha
AU - Hartnell, Sara
AU - Tauschmann, Martin
AU - Wilinska, Malgorzata E.
AU - Evans, Mark L.
AU - Mader, Julia K.
AU - Kojzar, Harald
AU - Dellweg, Sibylle
AU - Benesch, Carsten
AU - Arnolds, Sabine
AU - Pieber, Thomas R.
AU - Hovorka, Roman
PY - 2018
Y1 - 2018
N2 - Glucose excursion was assessed prior to and post hypoglycaemia to increase understanding of hypoglycaemia incidence and recovery during hybrid closed-loop insulin delivery. We retrospectively analysed data from 60 adults with type 1 diabetes who received, in a crossover randomized design, day-and-night hybrid closed-loop insulin delivery and insulin pump therapy, the latter with or without real-time continuous glucose monitoring. Over 4-week study periods, we identified hypoglycaemic episodes, defined as sensor glucose <3.0 mmol/L, and analysed sensor glucose relative to the onset of hypoglycaemia. We identified 377 hypoglycaemic episodes during hybrid closed-loop intervention vs 662 during control intervention (P<.001), with a predominant reduction of nocturnal hypoglycaemia. The slope of sensor glucose prior to hypoglycaemia was steeper during closed-loop intervention than during control intervention (P<.01), while insulin delivery was reduced (P<.01). During both day and night, participants recovered from hypoglycaemia faster when treated by closed-loop intervention. At 120minutes post hypoglycaemia, sensor glucose levels were higher during closed-loop intervention compared to the control period (P<.05). In conclusion, closed-loop intervention reduces the risk of hypoglycaemia, particularly overnight, with swift recovery from hypoglycaemia leading to higher 2-hour post-hypoglycaemia glucose levels.
AB - Glucose excursion was assessed prior to and post hypoglycaemia to increase understanding of hypoglycaemia incidence and recovery during hybrid closed-loop insulin delivery. We retrospectively analysed data from 60 adults with type 1 diabetes who received, in a crossover randomized design, day-and-night hybrid closed-loop insulin delivery and insulin pump therapy, the latter with or without real-time continuous glucose monitoring. Over 4-week study periods, we identified hypoglycaemic episodes, defined as sensor glucose <3.0 mmol/L, and analysed sensor glucose relative to the onset of hypoglycaemia. We identified 377 hypoglycaemic episodes during hybrid closed-loop intervention vs 662 during control intervention (P<.001), with a predominant reduction of nocturnal hypoglycaemia. The slope of sensor glucose prior to hypoglycaemia was steeper during closed-loop intervention than during control intervention (P<.01), while insulin delivery was reduced (P<.01). During both day and night, participants recovered from hypoglycaemia faster when treated by closed-loop intervention. At 120minutes post hypoglycaemia, sensor glucose levels were higher during closed-loop intervention compared to the control period (P<.05). In conclusion, closed-loop intervention reduces the risk of hypoglycaemia, particularly overnight, with swift recovery from hypoglycaemia leading to higher 2-hour post-hypoglycaemia glucose levels.
KW - Continuous glucose monitoring (CGM)
KW - CSII
KW - Glycaemic control
KW - Hypoglycaemia
KW - Insulin delivery
KW - Type 1 diabetes
UR - http://www.scopus.com/inward/record.url?scp=85045272198&partnerID=8YFLogxK
U2 - 10.1111/dom.13304
DO - 10.1111/dom.13304
M3 - Article
AN - SCOPUS:85045272198
SN - 1462-8902
JO - Diabetes, Obesity and Metabolism
JF - Diabetes, Obesity and Metabolism
ER -